Literature DB >> 16321766

Muir-Torre syndrome.

Giovanni Ponti1, Maurizio Ponz de Leon.   

Abstract

Muir-Torre syndrome is an autosomal-dominant skin condition of genetic origin, characterised by tumours of the sebaceous gland or keratoacanthoma that are associated with visceral malignant diseases. The cutaneous characteristics of Muir-Torre syndrome are sebaceous adenoma, epithelioma, carcinoma, or multiple keratoacanthomas, whereas visceral malignant diseases include colorectal, endometrial, urological, and upper gastrointestinal tumours. Although Muir-Torre syndrome has a striking familial association and features of autosomal-dominant transmission, it can arise in individuals without a family history or any known mutations. Clinical and biomolecular evidence has suggested that there are two types of Muir-Torre syndrome. The most common is a variant of hereditary non-polyposis colorectal cancer, which is characterised by defects in mismatch repair genes and early-onset tumours. The second type does not show deficiency in mismatch repair and its pathogenesis remains undefined. Diagnosis of these rare sebaceous lesions warrants the search for associated internal malignant diseases: the peculiarity of skin lesions and their biomolecular characterisation with microsatellite instability analysis and immunohistochemistry could be used to identify familial Muir-Torre syndrome, allowing clinicians to tailor a personalised programme to screen for skin and visceral malignant diseases in high-risk individuals.

Entities:  

Mesh:

Year:  2005        PMID: 16321766     DOI: 10.1016/S1470-2045(05)70465-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  55 in total

1.  Muir-torre syndrome: a case report.

Authors:  Heather J Higgins; Melissa Voutsalath; Jean M Holland
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

2.  The role of immunohistochemistry in the Muir-Torre Syndrome.

Authors:  Cláudia Marina Puga Barbosa Oliveira; Jullyene Gomes de Campos; Maiko Ramacos Maia; Larissa Eva dos Santos Lobo; Fábio Francesconi do Valle
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

3.  Inherited colorectal cancer syndromes.

Authors:  Robert Gryfe
Journal:  Clin Colon Rectal Surg       Date:  2009-11

4.  An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.

Authors:  Angela Arnold; Stewart Payne; Samantha Fisher; Diane Fricker; Judith Soloway; Susan M White; Marco Novelli; Kylie MacDonald; James Mackay; Richard Groves; Natalie Canham
Journal:  Fam Cancer       Date:  2007-02-24       Impact factor: 2.375

5.  Early gastric adenocarcinoma arising within foveolar-type dysplasia in a patient with Muir-Torre variant Lynch syndrome.

Authors:  Tristan F P McKnight; Amy E Noffsinger; Kara K Landry; Ovais Ahmed; Rebecca Wilcox
Journal:  Virchows Arch       Date:  2017-05-13       Impact factor: 4.064

6.  Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome.

Authors:  Anu R Lamba; Angela Y Moore; Todd Moore; Jennifer Rhees; Mildred A Arnold; C Richard Boland
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 7.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17

8.  Ileocecal adenocarcinoma and ureteral transitional cell carcinoma with multiple sebaceous tumors and keratoacanthomas in a case of muir-torre syndrome.

Authors:  Michael C Lynch; Bryan E Anderson
Journal:  Dermatol Res Pract       Date:  2010-08-15

9.  Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients.

Authors:  G Ponti; G Pellacani; C Ruini; A Percesepe; C Longo; V Desmond Mandel; F Crucianelli; G Gorelli; A Tomasi
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

10.  Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers.

Authors:  Giovanni Ponti; Gabriele Luppi; Lorena Losi; Alberto Giannetti; Stefania Seidenari
Journal:  J Hematol Oncol       Date:  2010-01-11       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.